Blank, Michael, Mathilda Mandel, Naama Dror, Arieh Solomon, Tilda Barlyia, & Dr. Gad Lavie. " Hypericin targets multiple signaling mediators in cancer cells generating unique, diverse anti-tumoral, anti-metastatic, and anti-angiogenic activities with evidence for clinical applicability." Medical Research Archives [Online], 5.3 (2017): n. pag. Web. 29 Mar. 2024